Farther Finance Advisors’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$33.8K Buy
6,618
+5,101
+336% +$27.8K ﹤0.01% 3741
2026
Q2
$8K Buy
1,517
+1,248
+464% +$6.57K ﹤0.01% 4565
2026
Q1
$1.12K Sell
269
-966
-78% -$4.65K ﹤0.01% 5077
2025
Q4
$5.94K Sell
1,235
-377
-23% -$1.82K ﹤0.01% 4208
2025
Q3
$8.16K Buy
1,612
+1,559
+2,942% +$6.89K ﹤0.01% 3535
2025
Q2
$214 Buy
+53
New +$172 ﹤0.01% 4195
2025
Q1
– Sell
-53
Closed -$225 – 4281
2024
Q4
$225 Hold
53
– – ﹤0.01% 3633
2024
Q3
$156 Sell
53
-1
-2% -$3 ﹤0.01% 3703
2024
Q2
$180 Hold
54
– – ﹤0.01% 3513
2024
Q1
$169 Sell
54
-3
-5% -$9 ﹤0.01% 3302
2023
Q4
$201 Buy
+57
New +$164 ﹤0.01% 3224

Other funds holding SRTA

Farther Finance Advisors's SRTA Position: Q3 2026 in Review

Farther Finance Advisors increased its Strata Critical Medical Inc (SRTA) stake by 336% in Q3 2026, buying an estimated $27.8K and bringing the position to 6,618 shares worth $33.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3741.

Farther Finance Advisors first reported a position in SRTA in Q4 2023 and has held it in 11 quarters since. 2 funds tracked by Wall St. Rank hold SRTA as of Q3 2026.

  • Farther Finance Advisors held 6,618 shares of Strata Critical Medical Inc worth $33.8K as of Q3 2026.
  • Farther Finance Advisors bought 5,101 Strata Critical Medical Inc shares in Q3 2026, an estimated $27.8K.
  • Strata Critical Medical Inc made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #3741 holding.
  • Farther Finance Advisors first reported a position in Strata Critical Medical Inc in Q4 2023 and has held it in 11 quarters since.
  • 2 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.